<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1969">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05135533</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00113565</org_study_id>
    <nct_id>NCT05135533</nct_id>
  </id_info>
  <brief_title>Neuromodulation and Dynamic Balance in Stroke</brief_title>
  <official_title>Cranial-nerve Non-invasive Neuromodulation and Dynamic Balance in Chronic Stroke Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Portable Neuromodulation Stimulator (PoNS) is non-invasive stimulation device placed on the&#xD;
      tongue to stimulate those brain regions understood to be important for maintaining balance.&#xD;
      This research study aims to collect evidence that PoNS therapy along with balance training&#xD;
      improves postural and walking stability post-stroke.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in gait speed</measure>
    <time_frame>Pre-treament and post-treatment following four weeks of intervention</time_frame>
    <description>Self-selected comfortable walking overground walking speed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in balance</measure>
    <time_frame>Pre-treament and post-treatment following four weeks of intervention</time_frame>
    <description>Functional Gait Assessment (FGA) assesses stability during walking. The score ranges between 0 and 30 with lower scores indicative of poor dynamic balance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Postural balance</measure>
    <time_frame>Pre-treament and post-treatment following four weeks of intervention</time_frame>
    <description>Sensory organization test (SOT) score that is the gold standard for quantifying postural balance and fall risk. The score ranges between 0 and 100 with lower scores indicative of poor balance.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Portable Neuromodulation Stimulator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Portable Neuromodulation Stimulation</intervention_name>
    <description>The PoNS group will receive electrical stimulation. Net direct current to the tongue electrode less than 1 ÂµA will be administered three times a week for four weeks.</description>
    <arm_group_label>Portable Neuromodulation Stimulator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>The Sham group will not receive electrical stimulation.</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gait and balance training</intervention_name>
    <description>During each session participants will walk on a treadmill at their fastest comfortable walking speed for 10 minutes followed by 30 minutes of balance training exercises three times a week for four weeks.</description>
    <arm_group_label>Portable Neuromodulation Stimulator</arm_group_label>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -&#xD;
&#xD;
        Persons post-stroke will be included in the study if they:&#xD;
&#xD;
        1) have either ischemic or hemorrhagic stroke at least six months since stroke onset; 2)&#xD;
        demonstrate residual paresis in the lower extremity (Fugl-Mayer lower extremity score &lt; 34)&#xD;
        3)are able to provide informed consent demonstrated by their ability to weigh the&#xD;
        consequences of participating versus not participating in the study 4)can walk at least 10&#xD;
        feet with and without assistive device 5)have Berg Balance Scale &lt;47.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Potential participants will be excluded from the study if they: 1) have a pacemaker or&#xD;
        other implanted device or have metal objects in the head; 2) have pre-existing neurological&#xD;
        disorders, dementia or previous stroke; and 3) have severe arthritis or orthopedic problems&#xD;
        that limit passive range of motion 4) have non-MR compatible implants or severe&#xD;
        claustrophobia 5) have areas of recent bleeding or open wounds; or areas that lack normal&#xD;
        sensation on the tongue 6) cancer treatment within the past year 7) nonremovable metal&#xD;
        orthodontic devices 8) oral health problems 9) history of seizures 10) chronic infectious&#xD;
        diseases 11) uncontrolled hypertension or diabetes 12) are pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Kautz, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shraddha Srivastava, PhD</last_name>
    <phone>843-792-6165</phone>
    <email>srivasts@musc.edu</email>
  </overall_contact>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 15, 2021</study_first_submitted>
  <study_first_submitted_qc>November 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Steven Kautz</investigator_full_name>
    <investigator_title>Depertment Chair</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data that underlie the results reported in the article, after de-identification.</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Immediately following publication no end date</ipd_time_frame>
    <ipd_access_criteria>anyone who wishes to access the data</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

